| Views | |
|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 177 |
| March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | |
|---|---|---|---|---|---|---|---|
| Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | 8 | 3 | 9 | 6 | 16 | 25 | 1 |
| Views | |
|---|---|
| Alkhawaldeh_Evaluation_23.pdf | 75 |
| Views | |
|---|---|
| United States | 46 |
| Canada | 35 |
| Germany | 5 |
| India | 4 |
| Vietnam | 4 |
| Japan | 3 |
| Australia | 2 |
| China | 2 |
| Latvia | 2 |
| Netherlands | 2 |
| Views | |
|---|---|
| Ottawa | 29 |
| Houston | 11 |
| Mountain View | 5 |
| San Francisco | 5 |
| Durham | 4 |
| Mumbai | 4 |
| Dearborn | 2 |
| Kanda | 2 |
| Sacramento | 2 |
| Washington | 2 |